Literature DB >> 7077006

Gentamicin pharmacokinetics: effect of aging in patients with normal renal function.

L A Bauer, R A Blouin.   

Abstract

The effects of aging on gentamicin total-body clearance, volume of distribution, and half-life were examined in 173 febrile patients with gram-negative infections. All had normal renal function, normal hematocrit levels, near-ideal body weights, and were not receiving concurrent penicillin therapy. In the 51 patients who were 20-39 years old, the mean clearance of gentamicin was 1.29 ml/min/kg, the volume of distribution was 0.23 l/kg, and the half-life was 2.2 hours. In the 59 patients 40-59 years old, these values were 1.35 ml/min/kg, 0.27 l/kg, and 2.1 hours; in the 63 patients 60-79 years old, they were 1.31 ml/min/kg, 0.26, and 2.4 hours. No significant difference was observed for any of the measures among the three age groups (P less than 0.05, analysis of variance). Linear regression revealed poor correlations between the individual measures and age. Since there is no change in gentamicin pharmacokinetics with aging, dosages do not need to be changed arbitrarily for older patients who have normal renal function.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7077006     DOI: 10.1111/j.1532-5415.1982.tb05618.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  6 in total

Review 1.  Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.

Authors:  K Mörike; M Schwab; U Klotz
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

Review 2.  Ontogeny of drug elimination by the human kidney.

Authors:  Nancy Chen; Katarina Aleksa; Cindy Woodland; Michael Rieder; Gideon Koren
Journal:  Pediatr Nephrol       Date:  2005-12-06       Impact factor: 3.714

Review 3.  Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly.

Authors:  E Triggs; B Charles
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

4.  Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.

Authors:  L A Bauer; R A Blouin
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 5.  Aminoglycosides in the Intensive Care Unit: What Is New in Population PK Modeling?

Authors:  Alexandre Duong; Chantale Simard; Yi Le Wang; David Williamson; Amélie Marsot
Journal:  Antibiotics (Basel)       Date:  2021-04-29

6.  Does "Birth" as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full-Term Neonates by Avoiding the Creatinine Bias.

Authors:  Farzaneh Salem; Trevor N Johnson; Arran B J Hodgkinson; Kayode Ogungbenro; Amin Rostami-Hodjegan
Journal:  J Clin Pharmacol       Date:  2020-09-03       Impact factor: 3.126

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.